Home / Companies / Caliway Biopharmaceuticals Co. Ltd. / 22 May 2026
Caliway Biopharmaceuticals Co. Ltd.: meeting of 22 May 2026
Votes reported on Form N-PX, item by item
40 Form N-PX filers reported votes at the Caliway Biopharmaceuticals Co. Ltd. meeting of 22 May 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
7 nominees; 89.2% of reported votes for; 32 filers withheld from or voted against at least one nominee.
497 vote records from 40 filers. 0 of the 39 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
71 vote records from 40 filers. 0 of the 39 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
211 vote records from 40 filers. 25 of the 39 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
140 vote records from 40 filers. 0 of the 39 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
10 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Caliway Biopharmaceuticals Co. Ltd. meeting?
40 Form N-PX filers reported votes at the meeting of 22 May 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Caliway Biopharmaceuticals Co. Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Caliway Biopharmaceuticals Co. Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Caliway Biopharmaceuticals Co. Ltd. with a meeting date within three days of 22 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.